Pharmacokinetic-pharmacodynamic relationships and dose response to meloxicam in horses with induced arthritis in the right carpal joint

American Journal of Veterinary Research

Volumn 65, Issue 11, 2004, Pages 1533-1541

  Toutain, Pierre Louis ^a   Cester, Corinne C ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; MELOXICAM;

ANIMAL EXPERIMENT; ANIMAL LAMENESS; ANIMAL MODEL; AREA UNDER THE CURVE; ARTHRITIS; ARTICLE; CARPAL BONE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; FEMALE; GAIT; HORSE DISEASE; LATIN SQUARE DESIGN; MALE; MEAN RESIDENCE TIME; NONHUMAN; PREDICTION; RANDOMIZATION; SCORING SYSTEM; STATISTICAL MODEL;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BIOMECHANICS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDPOINT DETERMINATION; HORSE DISEASES; HORSES; LAMENESS, ANIMAL; MODELS, BIOLOGICAL; THIAZINES; THIAZOLES;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 9444274775     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.1533     Document Type: Article

References (16)

1. Brideau C, Van Staden C, Chan CC. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats. Am J Vet Res 2001;62:1755-1760.
2. Lees P, Sedgwick AD, Higgins AJ, et al. Pharmacodynamics and pharmacokinetics of meloxicam in the horse. Br Vet J 1991;147:97-108.
3. Toutain PL. Pharmacokinetics/pharmacodynamics integration in drug development and dosage regimen optimization for veterinary medicine. AAPS PharmSci [serial online]. 2002;4:38. Available at: www.aapspharmsci.org/view.asp?art=ps040438. Accessed on Jun 3, 2004.
4. White GW, Jones EW, Stites T, et al. The efficacy of systematically administered anti-arthritic drugs in an induced equine carpitis model. J Equine Vet Sci 1996;16:139-145.
5. Yamaoka K, Tanigawara K, Nakagawa T, et al. A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn 1981;4:879-885.
6. Gibaldi M, Perrier D. Pharmacokinetics. New York: Marcel Dekker Inc, 1982.
7. Yamaoka K, Nakagawa T, Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978;6:165-175.
8. Dayneka NL, Garg V, Jusko WJ. Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 1993;21:457-478.
9. Krzyzanski W, Jusko WJ. Mathematical formalism for the properties of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 1997;25:107-123.
10. Krzyzanski W, Jusko WJ. Integrated functions for four basic models of indirect pharmacodynamic response. J Pharm Sci 1998;87:67-72.
11. Sharma A, Jusko WJ. Characterization of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 1996;24:611-635.
12. Koeppe P, Hamann C. A program for non-linear regression analysis to be used on desk-top computers. Comput Programs Biomed 1980;12:121-128.
13. Toutain PL, Autefage A, Legrand C, et al. Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling. J Vet Pharmacol Ther 1994;17:459-469.
14. Toutain PL, Cester CC, Haak T, et al. A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a COX-2 selective nonsteroidal anti-inflammatory drug in the dog. J Vet Pharmacol Ther 2001;24:43-55.
15. Sheiner LB, Hashimoto Y, Beal SL. A simulation study comparing designs for dose ranging. Stat Med 1991;10:303-321.
16. Burtin P, Mentre F, van Bree J, et al. Sparse sampling for assessment of drug exposure in toxicological studies. Eur J Drug Metab Pharmacokinet 1996;21:105-111.